• Explore /
  • Poster
  • / Interim analyses (IA) of the giredestrant (G), G + abemaciclib (A), and G + ribociclib (R) arms in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with estrogen receptor-positive, HER2-negative locally advanced/metastatic BC (ER+, HER2– LA/mBC).

Interim analyses (IA) of the giredestrant (G), G + abemaciclib (A), and G + ribociclib (R) arms in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with estrogen receptor-positive, HER2-negative locally advanced/metastatic BC (ER+, HER2– LA/mBC).

Abstract Poster

Authors

null

Mafalda Oliveira

Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

Mafalda Oliveira , Amir Sonnenblick , Hope S. Rugo , Kyung Hae Jung , Einav Gal Yam , Sara A. Hurvitz , Cristina Hernando , Seock-Ah Im , Vanessa Breton , Ann Collier , Richard B. Schwab , Jing Zhu , Joohyuk Sohn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Hormone Receptor-Positive

Clinical Trial Registration Number

NCT04802759

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 1061)

DOI

10.1200/JCO.2023.41.16_suppl.1061

Abstract #

1061

Poster Bd #

282

Abstract Disclosures

Similar Posters

First Author: Rachel M. Layman

First Author: Coralea Kappel

First Author: Erika P. Hamilton

First Author: Erica L. Mayer